Market Updates: OpenAI, Pharmaceuticals, and ETF Milestones

This chapter explores the latest happenings in the OpenAI sector, focusing on Sam Altman's equity opportunities. Additionally, it assesses stock performances for Bristol Myers Squibb and Costco, and wraps up with the rising popularity of ETFs in the US market.